SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-252039
Filing Date
2024-11-06
Accepted
2024-11-06 16:06:26
Documents
99
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d874174d10q.htm   iXBRL 10-Q 2739639
2 EX-31.1 d874174dex311.htm EX-31.1 10364
3 EX-31.2 d874174dex312.htm EX-31.2 10349
4 EX-32 d874174dex32.htm EX-32 4531
  Complete submission text file 0001193125-24-252039.txt   13736393

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20240930.xsd EX-101.SCH 99931
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20240930_cal.xml EX-101.CAL 52940
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20240930_def.xml EX-101.DEF 638294
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20240930_lab.xml EX-101.LAB 653561
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20240930_pre.xml EX-101.PRE 670451
102 EXTRACTED XBRL INSTANCE DOCUMENT d874174d10q_htm.xml XML 2846751
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 241430911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)